gsk peptide has been researched along with Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brichard, VG; Lejeune, D | 1 |
1 review(s) available for gsk peptide and Neoplasms
| Article | Year |
|---|---|
GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development.
Topics: Animals; Biomarkers, Tumor; Cancer Vaccines; Clinical Trials as Topic; Humans; Immunotherapy; Neoplasm Proteins; Neoplasms; Oligopeptides | 2007 |